Symposia Session MOSY03

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Photo shows: Wafaa El-Sadr, ICAP at Columbia University, Mailman School of Public Health, United States Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Photo shows: Z. Wu, Chinese Center for Diseases Control and Prevention, China Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Photo shows: G. Hirnschall, World Health Organization, Switzerland Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Photo shows: . Birx, The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), United States Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Photo shows: . Birx, The U.S. President's Emergency Plan for AIDS Relief (PEPFAR), United States Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS

8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015). Vancouver, Canada. Symposia Session (MOSY03): The Strategic Timing of AntiRetroviral Treatment (START) Study, Results and Their Implications Copyright: Marcus Rose/IAS